Patent Law

In Defense of Secondary Pharmaceutical Patents: A Response to the UN’s Guidelines for Pharmaceutical Patent Examination

[T]he Guidelines’ assumption that many types of pharmaceutical inventions are inherently obvious and undeserving of patent protection is incorrect and based on an oversimplified view of how these inventions come about. This Article provides an evidence-based response to the Guidelines that refutes, or at least qualifies, some of the significant conclusions and recommendations set forth by its author.


Attorneys’ Fee Awards in Patent Litigation – Emerging Trends

Andrew M. McCoy Faegre Baker Daniels LLP 300 North Meridian Street, Suite 2700 Indianapolis, IN 46204 Attorney Profile Section 285 of the Patent Act allows a prevailing party to recover attorneys’ fees in “exceptional” cases. [1]. In Octane Fitness, LLC v. Icon Health & Fitness, Inc., [2] and Highmark Inc. v. Allcare Health Management Systems, Inc., [3] the […]